pilocarpine has been researched along with Carcinoma in 4 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pilocarpine and placebo tablets were administered for 90 day periods in a double-blind, sequential crossover trial to 12 patients with postradiation xerostomia." | 9.06 | Effectiveness of pilocarpine in postradiation xerostomia. ( Daniels, TE; Greenspan, D, 1987) |
| " pilocarpine for at least for 12 weeks unless they had experienced unacceptable adverse effects." | 5.35 | Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese. ( Asakage, T; Ebihara, Y; Igaki, H; Nakagawa, K; Nakamura, N; Nakao, K; Ohtomo, K; Sasano, N; Shiraishi, K; Terahara, A; Yamashita, H, 2009) |
| "Pilocarpine and placebo tablets were administered for 90 day periods in a double-blind, sequential crossover trial to 12 patients with postradiation xerostomia." | 5.06 | Effectiveness of pilocarpine in postradiation xerostomia. ( Daniels, TE; Greenspan, D, 1987) |
| " pilocarpine for at least for 12 weeks unless they had experienced unacceptable adverse effects." | 1.35 | Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese. ( Asakage, T; Ebihara, Y; Igaki, H; Nakagawa, K; Nakamura, N; Nakao, K; Ohtomo, K; Sasano, N; Shiraishi, K; Terahara, A; Yamashita, H, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aframian, DJ | 1 |
| Nahlieli, O | 1 |
| Knopf, A | 1 |
| Lukach, L | 1 |
| Qawasmeh, N | 1 |
| Nadler, C | 1 |
| Choi, JS | 1 |
| Hong, SB | 1 |
| Hyun, IY | 1 |
| Lim, JY | 1 |
| Kim, YM | 1 |
| Nakamura, N | 1 |
| Sasano, N | 1 |
| Yamashita, H | 1 |
| Igaki, H | 1 |
| Shiraishi, K | 1 |
| Terahara, A | 1 |
| Asakage, T | 1 |
| Nakao, K | 1 |
| Ebihara, Y | 1 |
| Ohtomo, K | 1 |
| Nakagawa, K | 1 |
| Greenspan, D | 1 |
| Daniels, TE | 1 |
1 trial available for pilocarpine and Carcinoma
| Article | Year |
|---|---|
Effectiveness of pilocarpine in postradiation xerostomia.
Topics: Carcinoma; Head and Neck Neoplasms; Humans; Parotid Gland; Pilocarpine; Radiotherapy; Salivation; Xe | 1987 |
3 other studies available for pilocarpine and Carcinoma
| Article | Year |
|---|---|
Preserving formerly impaired salivary gland function in radioiodine-treated thyroid papillary carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Endoscopy, Digestive System; Female; Humans; Iodine Radioiso | 2013 |
Effects of Salivary Secretion Stimulation on the Treatment of Chronic Radioactive Iodine-Induced Sialadenitis.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Chronic Disease; Female; H | 2015 |
Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Carcinoma; Dose-Response Relationship, Drug; Drug Admin | 2009 |